Changjiang Runfa Health Industry Co., Ltd.

SZSE:002435 Stock Report

Market Cap: CN¥457.3m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Changjiang Runfa Health Industry Valuation

Is 002435 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 002435 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 002435 (CN¥0.37) is trading below our estimate of fair value (CN¥0.97)

Significantly Below Fair Value: 002435 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 002435?

Key metric: As 002435 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 002435. This is calculated by dividing 002435's market cap by their current revenue.
What is 002435's PS Ratio?
PS Ratio0.2x
SalesCN¥3.02b
Market CapCN¥457.31m

Price to Sales Ratio vs Peers

How does 002435's PS Ratio compare to its peers?

The above table shows the PS ratio for 002435 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average5.7x
600671 Hangzhou TianMuShan Pharmaceutical EnterpriseLtd
6.8xn/aCN¥1.1b
600781 FUREN Group PharmaceuticalLtd
0.3xn/aCN¥482.9m
603963 Dali Pharmaceuticalco.Ltd
11xn/aCN¥681.1m
300108 Ji Yao Holding Group
4.7xn/aCN¥1.7b
002435 Changjiang Runfa Health Industry
0.2xn/aCN¥457.3m

Price-To-Sales vs Peers: 002435 is good value based on its Price-To-Sales Ratio (0.2x) compared to the peer average (7x).

Price to Sales Ratio vs Industry

How does 002435's PS Ratio compare vs other companies in the CN Pharmaceuticals Industry?

6 CompaniesPrice / SalesEstimated GrowthMarket Cap
Industry Avg.3.5x12.3%
002435 Changjiang Runfa Health Industry
 0.2xn/aUS$63.75m
600664 Harbin Pharmaceutical Group
0.6xn/aUS$1.28b
000411 Zhejiang Int'l GroupLtd
0.2xn/aUS$758.59m
002435 0.2xIndustry Avg. 3.5xNo. of Companies36PS02.85.68.411.214+
6 CompaniesEstimated GrowthMarket Cap
Industry Avg.3.5x18.8%
002435 Changjiang Runfa Health Industry
 0.2xn/aUS$63.75m
No more companies

Price-To-Sales vs Industry: 002435 is good value based on its Price-To-Sales Ratio (0.2x) compared to the CN Pharmaceuticals industry average (3.1x).

Price to Sales Ratio vs Fair Ratio

What is 002435's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

002435 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.2x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 002435's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

China Resources Double-Crane PharmaceuticalLtd

CN¥21.4b

China Resources Double-Crane Pharmaceutical Co.,Ltd.

600062

CN¥20.80

7D

-3.9%

1Y

12.1%

Dong-E-E-JiaoLtd

CN¥36.4b

Research and development, production, and sale of Ejiao and a series of Chinese patent medicines, health foods, and foods.

423

CN¥56.60

7D

-3.0%

1Y

13.2%

Jiangsu Kanion PharmaceuticalLtd

CN¥8.1b

Researches and develops, produces, and sells Chinese medicines.

600557

CN¥14.29

7D

-4.2%

1Y

-23.6%